Feed ZLAB
ZL

Zai Lab ZLAB · NASDAQ

$24.03 +9.03% (+$1.99)

Market cap
$2.46B
Enterprise value
$2.11B
P/E
-
Forward P/E
-
PEG
-
P/S
5.5x
P/FCF
-
EV/EBITDA
-
ROIC
-29.3%
Bruto marža
56.5%
Neto marža
-41.9%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
-
Beta
0.83
Free float
93.4%

O podjetju

Zai Lab Limited is a Chinese biotechnology company specializing in the development and commercialization of innovative drugs focused on the treatment of oncology and autoimmune diseases. The company concentrates on developing products in the fields of immunotherapy, targeted therapy, and other advanced treatment methods. Zai Lab collaborates with leading global pharmaceutical and biotechnology companies to bring the latest treatment options to the Chinese market and the broader Asia region, ensuring that patients have access to new therapies.

Sector

Healthcare

Industry

Biotechnology

CEO

Ying Du

Employees

1,784

Headquarters

Shanghai

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.